UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 582

Sortiert nach

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

Oncogene, 2012-02, Vol.31 (8), p.978-991

2012

Volltextzugriff (PDF)

Changes in circulating microRNA levels associated with prostate cancer

British journal of cancer, 2012-02, Vol.106 (4), p.768-774

2012

Volltextzugriff (PDF)

Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy

Nature communications, 2020-10, Vol.11 (1), p.5070-13, Article 5070

2020

Volltextzugriff (PDF)

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

Oncogene, 2012-04, Vol.31 (17), p.2153-2163

2012

Volltextzugriff (PDF)

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Oncogene, 2012-10, Vol.31 (41), p.4460-4471

2012

Volltextzugriff (PDF)

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Nature communications, 2021-09, Vol.12 (1), p.5307-5307, Article 5307

2021

Volltextzugriff (PDF)

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies

Translational oncology, 2018-10, Vol.11 (5), p.1160-1170

2018

Volltextzugriff (PDF)

The expression of SOCS is altered in rheumatoid arthritis

Rheumatology (Oxford, England), 2007-10, Vol.46 (10), p.1538-1546

2007

Volltextzugriff (PDF)

2519 Role of miR-32 in prostate cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S480-S481

2015

Volltextzugriff (PDF)

Tumor features and survival after radical prostatectomy among antidiabetic drug users

Prostate cancer and prostatic diseases, 2016-12, Vol.19 (4), p.367-373

2016

Volltextzugriff (PDF)

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

British journal of cancer, 2007-01, Vol.96 (2), p.352-356

2007

Volltextzugriff (PDF)

Androgen receptor gene and hormonal therapy failure of prostate cancer

The American journal of pathology, 1998-01, Vol.152 (1), p.1-9

1998

Volltextzugriff (PDF)

miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (11), p.2326-2336

2015

Volltextzugriff (PDF)

20 miR-25 is a key regulator of prostate cancer invasiveness by modulation of the cross-talk between Notch and TGF-β signaling

European journal of cancer (1990), 2014-11, Vol.50, p.12-13

2014

Volltextzugriff (PDF)

12: Proffered Paper: The life history of lethal metastatic prostate cancer (The UK prostate cancer working group of the International Cancer Genome Consortium)

European journal of cancer (1990), 2014-07, Vol.50, p.S4-S4

2014

Volltextzugriff (PDF)

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

The Journal of urology, 2000-12, Vol.164 (6), p.1992-1995

2000

Volltextzugriff (PDF)

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells

Oncogene, 2008-08, Vol.27 (36), p.4865-4876

2008

Volltextzugriff (PDF)

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth

Oncogene, 2006-03, Vol.25 (9), p.1358-1366

2006

Volltextzugriff (PDF)

Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer

The American journal of pathology, 2001-12, Vol.159 (6), p.2089-2094

2001

Volltextzugriff (PDF)

Steroids and prostate cancer

The Journal of steroid biochemistry and molecular biology, 2004-11, Vol.92 (4), p.219-220

2004

Volltextzugriff (PDF)

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

JNCI : Journal of the National Cancer Institute, 1992-06, Vol.84 (11), p.883-887

1992

Volltextzugriff (PDF)

Molecular genetics of prostate cancer

Annals of medicine (Helsinki), 2001, Vol.33 (2), p.130-141

2001

Volltextzugriff (PDF)

Overexpression and gene amplification of BAG-IL in hormone-refractory prostate cancer

The Journal of pathology, 2007-08, Vol.212 (4), p.395-401

2007

Volltextzugriff (PDF)

The Mutational Landscape of Prostate Cancer

European urology, 2013-10, Vol.64 (4), p.567-576

2013

Volltextzugriff (PDF)

Molecular Biology of Progression of Prostate Cancer

European urology, 1999, Vol.35 (5-6), p.351-354

1999

Volltextzugriff (PDF)

1 – 25 von 582

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(450)
Mit Volltextzugriff
(440)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

Changes in circulating microRNA levels associated with prostate cancer

Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies

The expression of SOCS is altered in rheumatoid arthritis

2519 Role of miR-32 in prostate cancer

Tumor features and survival after radical prostatectomy among antidiabetic drug users

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

Androgen receptor gene and hormonal therapy failure of prostate cancer

miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression

20 miR-25 is a key regulator of prostate cancer invasiveness by modulation of the cross-talk between Notch and TGF-β signaling

12: Proffered Paper: The life history of lethal metastatic prostate cancer (The UK prostate cancer working group of the International Cancer Genome Consortium)

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth

Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer

Steroids and prostate cancer

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

Molecular genetics of prostate cancer

Overexpression and gene amplification of BAG-IL in hormone-refractory prostate cancer

The Mutational Landscape of Prostate Cancer

Molecular Biology of Progression of Prostate Cancer

Suchergebnisse filtern